baber/WOPTO huggingface dataset:
Patent CA-3103575-A1 (CA)
Title: Methods for producing potassium sulfate and sodium chloride from wastewater
Inventor: YOUNG CHRISTOPHER MICHAEL
IPC: C02F9/00
Filed: 2017-11-22
Abstract: A method for producing potassium sulfate from a waste stream is disclosed. The waste stream is concentrated to form a brine or slurry. In a mirabilite crystallizer, forming mirabilite crystals and a mirabilite crystallizer liquor. Separating and mixing the mirabilite crystals with a potassium liquor to produce glaserite crystals in a glaserite reactor or crystallizer. Separating and directing the glaserite crystals to a potassium sulfate reactor. Mixing a potassium chloride source with the glaserite crystals to form potassium sulfate crystals and the potassium liquor. Recycling the potassium liquor to the glaserite reactor or crystallizer. Filtering the mirabilite crystallizer liquor to form a filtrate or permeate stream depleted in sulfate and a retentate or reject stream rich in sulfate, the retentate or reject stream recycled to the mirabilite crystallizer. Directing the filtrate or permeate stream to a sodium chloride crystallizer and crystallizing sodium chloride crystals and separating the sodium chloride crystals.
Patent CA-3106224-A1 (CA)
Title: Ice maker, ice dispensing assembly, and method of deploying ice maker
Inventor: KNATT KEVIN
IPC: F25C1/00
Filed: 2021-01-14
Abstract: 3513646.0099 ABSTRACT An ice maker includes a prefabricated cabinet with a base that defines a bottom of an ice maker housing. An access side of the cabinet defines a doorway for accessing an ice making device in the housing. A prefabricated door for opening and closing the doorway has a bottom spaced apart above the bottom of the housing. The ice maker can be mounted on a prefabricated receptacle so that the bottom of the housing is flush with a top of the receptacle and the door can clear a protruding dispenser unit as it swings on its hinge. The prefabricated cabinet may include a door mount that couples the door to the cabinet so that the bottom of the door is spaced above the bottom of the ice maker. CORE/3513646.00991154607813.1 Date Recue/Date Received 2021-01-14
Patent CA-3106833-A1 (CA)
Inventor: MARSCHALL MANFRED
IPC: C07K14/03
Filed: 2019-07-19
Abstract: The present invention generally provides for a novel NEC-targeted strategy for the development of antiherpesviral drugs as well as for a novel antiviral strategy targeting the viral-cellular nuclear egress complex (NEC) for a small molecule-based therapy or prophylaxis to control infections with human cytomegalovirus or other pathogenic viruses of the group of the Herpesviridae. Methods for screening agents / compounds /small molecules modulating/ inhibiting the nuclear egress complex of Herpesviridae are provided as well. Specifically novel drug targets of the viral nuclear egress complex of viruses of the Herpesviridae are provided.
Patent CA-3106971-A1 (CA)
Inventor: MADASU SRINATH
IPC: E21B41/00
Filed: 2018-08-30
Abstract: A history-matched oilfield model that facilitates well system operations for an oilfield is generated using a Bayesian optimization of adjustable parameters based on an entire production history. The Bayesian optimization process includes stochastic modifications to the adjustable parameters based on a prior probability distribution for each parameter and a model error generated using historical production measurement values and corresponding model prediction values for various sets of test parameters.
Patent CA-3113629-A1 (CA)
Inventor: VALLE CAMILA DO
IPC: B32B27/32
Filed: 2019-09-11
Abstract: L'invention concerne un film thermorétractable qui comprend un film monocouche ou un film multicouche ayant une première couche, une seconde couche, et au moins une couche interne entre les première et seconde couches, et un revêtement sur une surface externe du film monocouche ou de la première couche ou de la seconde couche du film multicouche. Le revêtement est formé à partir d'une composition aqueuse à base d'acrylique.
Patent CA-3114948-A1 (CA)
Title: Device for measuring tyre pressure
Inventor: ZABULON JOEL
IPC: B60C23/04
Filed: 2019-10-02
Abstract: Device (3) for measuring the pressure of a vehicle wheel (3), comprising a fixed portion (5) and a movable portion (14) intended to be rotated by the wheel, the fixed portion comprising a first printed circuit (7) on which at least one first track is formed defining a first winding, the moving portion comprising a second printed circuit (16) on which at least one second track is formed defining a second winding, the second printed circuit being designed to be connected to a pressure sensor (15), the first winding and the second winding being coupled to form a wireless communication channel, the measuring device being designed so that the pressure sensor is electrically powered by the fixed portion via the wireless communication channel, and so that uplink data comprising the pressure measurement data are transmitted to the fixed portion (5) from the moving portion (14) via the wireless communication channel.
Patent CA-3115537-A1 (CA)
Inventor: NORELL NANCY
IPC: D06F1/12
Filed: 2021-04-19
Abstract: A device including two frames, hingedly attached one to the other, for releasably securing a dish cloth (or multiple dish cloths, or other fabric items) therebetween, for sanitizing within a dishwasher.
Patent CA-3116396-A1 (CA)
Inventor: BUSCH ALEXANDRE
IPC: E04B2/70
Filed: 2018-10-17
Abstract: The invention relates to a modular system (1) for constructing a timber-framed building (2), comprising a plurality of timber-framed modules (3A, 3B, 3B) which have a rectangular parallelepipedal cross-section and are composed of a series of vertical posts (4) which are continuous up the entire height thereof and are interconnected in pairs by at least two horizontal joists (5), including at least two modules (3A, 3B) which are assembled horizontally, thereby defining a wall (8) between said modules (3A, 3B), and at least two timber-framed modules (3A, 3C) which are assembled vertically, at least one wall post (4a) being provided between said vertical posts (4). In particular: - at least said wall posts (4a) of horizontally adjacent modules (3A, 3B) are offset with respect to one another and overlap, at least in part; - and the posts (4) of an upper module (3C) rest on the posts (4) of a lower module (3A), directly or indirectly by means of a layer of non-compressible material. The invention further relates to a timber-framed building (2), comprising at least one modular system (1) of this type.
Patent CA-3117041-A1 (CA)
Title: Device and method for forming electroformed component
Inventor: TAJIRI GORDON
IPC: C25D1/00
Filed: 2018-10-18
Abstract: A forming manifold and method for electroforming a component, including providing an electroforming cathode disposed within a first bath tank having a solution with a first metal ion concentration, overlaying at least a portion of the electroforming cathode with a forming manifold having a housing and applying a voltage to the electroforming cathode while disposed within the first bath tank.
Patent CA-3118034-A1 (CA)
Inventor: SCHWENDT KIM ELLEN
IPC: A61P33/06
Filed: 2019-12-20
Abstract: The present invention is directed to a coding RNA for a Malaria vaccine. The coding RNA comprises at least one heterologous untranslated region (UTR), preferably a 3'-UTR and/or a 5'-UTR, and a coding region encoding at least one antigenic peptide or protein derived from a Malaria parasite, in particular at least one antigenic protein derived from circumsporozoite protein (CSP) of a Malaria parasite (e.g. Plasmodium falciparum). The present invention is also directed to compositions and vaccines comprising said coding RNA in association with a polymeric carrier, a polycationic protein or peptide, or a lipid nanoparticle (LNP). Further, the invention concerns a kit, particularly a kit of parts comprising the coding RNA, or the composition, or the vaccine. The invention is also directed to a method of treating or preventing Malaria, and the first and second medical uses of the coding RNA, the composition, the vaccine, and the kit.
Patent CA-3118803-A1 (CA)
Inventor: FLUCH RAINER
IPC: C22C38/42
Filed: 2019-12-19
Abstract: The invention relates to a drill string component, particularly a drill collar, MWD or LWD component for use in oilfield technology and particularly in deep hole drilling, consisting of an alloy with the following composition (all indications in wt.%) as well as inevitable impurities: the elements carbon (C) 0.01-0.25, silicon (Si) < 0.5, manganese (Mn) 3.0 -8.0, phosphorus (P) < 0.05, sulphur (S) < 0.005, iron (Fe) residuum, chrome (Cr) 23.0 30.0, molybdenum (Mo) 2.0 4.0, nickel (Ni) 10.0 16.0, vanadium (V) < 0.5, tungsten (W) < 0.5, copper (Cu) < 0.5, cobalt (Co) < 5, titanium (Ti) < 0.1, aluminium (Al) < 0.2, niobium (Nb) < 0.1, boron (B) < 0.01, and nitrogen (N) 0.50-0.90.
Patent CA-3118978-A1 (CA)
Inventor: TALON CHRISTIAN
IPC: B65D85/804
Filed: 2019-11-08
Abstract: A pack (1) with an inner volume in which a food or beverage ingredient is stored and in which a beverage is produced when water is introduced inside. The pack (1) comprises at least one inlet configured to supply water in the inner volume of the pack (1) and one outlet (11) for dispensing a beverage from the inner volume of the pack (1). The pack (1) comprises a semi-rigid or rigid shell (2), the shell (2) comprises a main plane wall (20) surrounded by a peripheral edge (21), and a cover part (3) sealed on the peripheral edge (21), the shell (2) and the cover part (3) defining therebetween said inner volume.
Patent CA-3119715-A1 (CA)
Title: Syringe suitable for hydrogen peroxide solution and kit thereof
Inventor: YAMASHITA SHOGO
IPC: A61M5/32
Filed: 2019-10-18
Abstract: Provided is a syringe which inhibits hydrogen peroxide from decomposing. The syringe includes a part where the syringe comes into direct contact with the hydrogen peroxide solution, the material of the syringe part being a cycloolefin polymer (COP) or a cycloolefin copolymer (COC).
Patent CA-3120293-A1 (CA)
Title: Non-regular electrical stimulation patterns for improved efficiency in treating parkinson's disease
Inventor: GRILL WARREN M
IPC: A61N1/36
Filed: 2013-06-17
Abstract: Systems and methods for stimulation of neurological tissue generate stimulation trains with temporal patterns of stimulation, in which the interval between electrical pulses (the inter-pulse intervals) changes or varies over time. Compared to conventional continuous, high rate pulse trains having regular (i.e., constant) inter-pulse intervals, the non-regular (i.e., not constant) pulse patterns or trains that embody features of the invention provide a lower average frequency. The systems and methods for stimulation of neurological tissue may be used to increase the efficacy of treatment in patients with Parkinson's Disease.
Patent CA-3121761-A1 (CA)
Title: Therapeutic uses of empagliflozin
Inventor: BROEDL ULI
IPC: A61K31/7048
Filed: 2014-04-03
Abstract: The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing metabolic disorders, such as type 1 or type 2 diabetes mellitus or pre-diabetes, in patients with renal impairment or chronic kidney disease (CKD).
Patent CA-3122652-A1 (CA)
Title: Systems and methods for facilitating the purchase of one or more vehicles
Inventor: HYGEMA MELANIE ALLGOOD
IPC: G06Q30/06
Filed: 2013-09-03
Abstract: Illustrative embodiments may generally be directed to, among other things, a platform for providing information to one or more consumers to facilitate the purchase of one or more vehicles. In one embodiment, the platform may provide information associated with one or more OEMs and their vehicle product lines.  In another embodiment, the platform may facilitate selecting, building, modifying, comparing, and/or purchasing one or more vehicles. In yet another embodiment, the platform may determine inventory data corresponding to actual available inventory at one or more dealerships.
Patent CA-3126833-A1 (CA)
Title: A method of gene editing
Inventor: RUSSELL DAVID W
IPC: A61K31/4545
Filed: 2020-01-29
Abstract: Disclosed herein are methods of editing a gene in a cell that involve contacting the cell with a replication fork modulator, as well as edited cells and their methods of use.
Patent CA-3126846-A1 (CA)
Title: Heat transfer compositions comprising r-1225ye(e)
Inventor: MINOR BARBARA HAVILAND
IPC: C09K5/04
Filed: 2020-03-03
Abstract: The present application relates to compositions comprising (E)-1,2,3,3,3-pentafluoro-1-propene (i.e., R-1225ye(E) or HFO-1225ye(E)) that are useful in refrigeration, air conditioning, or heat pump systems. Methods of replacing R-1234ze(E) in refrigeration, air conditioning, or heat pump systems are also provided.
Patent CA-3128950-A1 (CA)
Inventor: OSTROVSKY ILYA
IPC: C09D183/04
Filed: 2020-02-07
Abstract: The present invention refers to an improved method for applying silane-based coatings to solid surfaces, in particular metal surfaces, wherein a solid surface, in particular an optionally anodized or conversion-coated metal surface, is i) optionally cleaned, etched and/or desmutted, ii) brought into contact with at least one unhydrolyzed silane such that an unhydrolyzed silane layer is formed on the solid surface, iii) brought into contact with water such that the silane layer is at least partially hydrolyzed, iv) at least partially dried such that residues of water and alkanol are at least partially removed from the solid surface, v) optionally heated such that the at least partially hydrolyzed and least partially dried silane layer is cured, and vi) in case that step v) is conducted, optionally painted. The present invention also relates to an according silane-containing composition as well as to a solidsurface, in particular a metal surface, with an according silane-based coating and its use in the field of transportation industry or electrically conductive assembling.
Patent CA-3134610-A1 (CA)
Inventor: SPIEGEL DAVID
IPC: A61P37/00
Filed: 2019-04-08
Abstract: The present invention is directed to bifunctional small molecules which contain a circulating protein binding moiety (CPBM) linked through a linker group to a cellular receptor binding moiety (CRBM) which is a membrane receptor of degrading cell such as a hepatocyte or other degrading cell. In embodiments, the (CRBM) is a moiety which binds to asialoglycoprotein receptor (an asialoglycoprotein receptor binding moiety, or ASGPRBM) of a hepatocyte. In additional embodiments, the (CRBM) is a moiety which binds to a receptor of other cells which can degrade proteins, such as a LRP1, LDLR, FcyRI, FcRN, Transferrin or Macrophage Scavenger receptor. Pharmaceutical compositions based upon these bifunctional small molecules represent an additional aspect of the present invention. These compounds and/or compositions may be used to treat disease states and conditions by removing circulating proteins through degradation in the hepatocytes or macrophages of a patient or subject in need of therapy. Methods of treating disease states and/or conditions in which circulating proteins are associated with the disease state and/or condition are also described herein.
Patent CA-3134902-A1 (CA)
Inventor: LI XIAODONG
IPC: C07D403/12
Filed: 2020-04-08
Abstract: Provided is a novel class of orally and/or topically available, selective and potent JAK inhibitors as safe and effective therapeutics against various diseases and disorders. Also provided is pharmaceutical composition of these compounds and methods of their preparation and use thereof.
Patent CA-3137105-A1 (CA)
Title: Motorized implant delivery system
Inventor: BECERRA MATTHEW MICHAEL
IPC: A61F2/95
Filed: 2020-04-21
Abstract: Systems, apparatuses, and methods disclosed herein are provided for a motorized implant delivery system. The delivery system may utilize a processor for control of at least one motor for actuating a delivery apparatus. The delivery system may include sensors configured sense one or more of a condition of the patient's body or a condition of the delivery apparatus. The processor may process the signals provided by the sensors, which may comprise feedback signals to the processor.
Patent CA-3138454-A1 (CA)
Title: Inhaler system
Inventor: MILTON-EDWARDS MARK
IPC: G16H20/13
Filed: 2020-04-30
Abstract: Provided is a system (10) for determining a probability of a CORD exacerbation in a subject. The system comprises a first inhaler (100) for delivering a rescue medicament to the subject. The rescue medicament may be suitable for treating the subject's acute respiratory disease, for example by effecting rapid dilation of the bronchi and bronchioles upon inhalation of the medicament. The first inhaler has a use-detection system (12B) configured to determine a rescue inhalation performed by the subject using the first inhaler. The system optionally includes a second inhaler for delivering a maintenance medicament to the subject during a routine inhalation. A sensor system (12A) is configured to measure a parameter relating to airflow during the rescue inhalation and/or during the routine inhalation, when the second inhaler is included in the system. The system further comprises a processor (14) configured to determine a number of the rescue inhalations during a first time period, and receive the parameter measured for at least some of the rescue and/or routine inhalations. The processor then determines, using a weighted model, the probability of the CORD exacerbation based on the number of rescue inhalations and the parameters. The model is weighted such that the parameters are more significant in the probability determination than the number of rescue inhalations. Further provided is a method for determining the probability of a COPD exacerbation in a subject, which method employs the weighted model.
Patent CA-3140672-A1 (CA)
Title: Biotherapy for viral infections using biopolymer based micro/nanogels
Inventor: NAIR MADHAVAN
IPC: A61K35/768
Filed: 2020-06-05
Abstract: A method of treatment or prevention of HIV and other viral infection comprising the administration of a biopolymer-based hydrogel nanoparticles and/or microparticles. In preferred embodiments, the particles comprise chitosan, hydroxyethyl cellulose (HEC), and linseed oil polyol. These biopolymer-based hydrogel nanoparticles and/or microparticles are antiviral agents that can be employed alone or in combination with other drugs for treatment of the viral infection. Further, the pre-treatment with the particles is highly effective at inhibiting viruses. Therefore, this antiviral biopolymer-based hydrogel nanoparticles and/or microparticles may also be employed as a prophylactic.
Patent CA-3141482-A1 (CA)
Title: Video signal processing method and device on basis of reference between components
Inventor: SIM DONG GYU
IPC: H04N19/593
Filed: 2019-06-10
Abstract: In a video signal processing method and device according to the present invention, a first prediction value of a chrominance block is derived by means of a sample of a luminance block, a compensation parameter is calculated on the basis of a predetermined reference region, a second prediction value of the chrominance block is derived by applying the compensation parameter to the first prediction value, and the chrominance block can be restored on the basis of the second prediction value of the chrominance block.
Patent CA-3150422-A1 (CA)
Title: A container for foodstuffs and a method for manufacturing said container
Inventor: ZANARELLA CLAUDIO ERNESTINO
IPC: B65D5/48
Filed: 2020-07-28
Abstract: A container (1) for foodstuffs comprises a containment body (2) having a polygonal bottom wall (3) and perimeter side walls (4) connected to each other and to the polygonal bottom wall (3) thereby defining a food containment volume (V) open at an upper opening. At least two side flaps (5) and one upper flap (6) extend from each perimeter side wall (4). Each side flap (5) is connected to the respective side wall (4) through a respective side folding line (5a) and abuts against and is bonded to a respective adjacent side flap (5), defining a supporting element (7) outside the containment volume (V). Each upper flap (6) is connected to the respective side wall (4) through a respective first upper folding line (6a) along which it is folded away from the containment volume (V) thereby defining an edge portion (8) of the container suitable to receive a closure element.
Patent CA-3150743-A1 (CA)
Inventor: BORNHOLDT NICK
IPC: C08G8/00
Filed: 2020-08-17
Abstract: L'invention concerne un mélange durcissable comprenant au moins un composé organique ayant des groupes hydroxyles phénoliques et au moins un carbonate organique cyclique multifonctionnel utilisé en tant qu'agent de réticulation, un procédé de durcissement dudit composé organique ayant des groupes hydroxyles phénoliques avec au moins un carbonate organique cyclique multifonctionnel, et des liants pour des compositions de revêtement, des compositions adhésives ou des compositions de charge comprenant au moins un composé organique ayant des groupes hydroxyles phénoliques et au moins un carbonate organique cyclique multifonctionnel.
Patent CA-3150882-A1 (CA)
Title: System and method to determine low-speed and stationary state of a rail vehicle
Inventor: LE ADAM
IPC: G01S13/87
Filed: 2020-10-09
Abstract: A system for determining a stationary state of a rail vehicle on a track includes a first radar mounted at an end of the rail vehicle and a second radar mounted at another end of the rail vehicle. A speed sensor is mounted on the rail vehicle. A series of fixed reflective track features are found along the track. A processing unit, communicably connected with the speed sensor, the first radar and the second radar receives data from the first radar and the second radar corresponding to the distance to the fixed reflective track features and determines the stationary state or low-speed condition of the rail vehicle and checks the state or condition by comparing it with an output of the speed sensor.
Patent CA-3152754-A1 (CA)
Title: Therapie cellulaire ex vivo a base d'oligonucleotides
Inventor: JASCHINSKI FRANK
IPC: A61K35/15
Filed: 2020-10-05
Abstract: La présente invention concerne un procédé de réduction de l'expression d'un ARN cible dans une cellule isolée dans la préparation d'une thérapie cellulaire, comprenant l'incubation de la cellule Isolée comprenant l'ARN cible avec un oligonucléotide antisens sans utiliser de moyen de transfection, l'oligonucléotide antisens étant administré à la cellule isolée au moins une fois dans une période de temps de 0 à 21 jours, l'oligonucléotide antisens s'hybride avec l'ARN cible et réduit la transcription de l'ARN cible, réduit l'expression de la protéine codée par l'ARN cible ou une combinaison de ces derniers jusqu'à 8 semaines à partir du jour 0 de l'incubation avec l'oligonucléotide antisens. L'invention concerne en outre une cellule isolée pouvant être obtenue par le procédé de la présente invention et une composition pharmaceutique comprenant la cellule isolée. La cellule isolée et la composition pharmaceutique sont utilisées dans un procédé de prévention et/ou de traitement d'une maladie.